ALCOX:EPA
NicOx SA
€0.29
arrow_downward
-1.03%(-0.0030) 1D
Oct 23, 12:43:21 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.29
High
€0.29
Low
€0.29
Mkt. cap
28.30M
Avg. vol.
160.36K
Volume
12.96K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
99.07M
No. of employees
10
Open
€0.29
High
€0.29
Low
€0.29
Mkt. cap
28.30M
Avg. vol.
160.36K
Volume
12.96K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
99.07M
No. of employees
10
News stories
From web sources and news partners
FinancialContent
·
43 minutes ago
Flagstar Financial (NYSE:FLG) misses Q3 2026 revenue estimates
Yahoo Finance
·
23 minutes ago
Invesco NASDAQ 100 ETF (QQQM) Adds NVIDIA and Apple on Wednesday
Investor's Business Daily
·
8 hours ago
Dow Jones Futures: Moderna Crashes, Meta Fuels AI Meltdown, But Warren Buffett Market Thriving
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com